Despite considerable interest in the development of biosensors that can measure analyte concentrations with a dynamic range spanning many orders of magnitude, this goal has proven difficult to achieve. We describe here a modular biosensor architecture that integrates two different readout mechanisms into a single-molecule construct that can achieve target detection across an extraordinarily broad dynamic range. Our dual-mode readout DNA biosensor (DMRD) combines an aptamer and a DNAzyme to quantify ATP with two different mechanisms, which respond to low (micromolar) and high (millimolar) concentrations by generating distinct readouts based on changes in fluorescence and absorbance, respectively. Importantly, we have also devised regulatory strategies to finely tune the target detection range of each sensor module by controlling the target-sensitivity of each readout mechanism.
Introduction
In nature, many biological receptors have evolved the capacity to respond to ligands across a broad dynamic range of concentrations. [1] [2] This is important, as their cognate molecular targets, such as hormones, metal ions, and viruses, may be present across a broad spectrum of concentrations. [3] [4] [5] For instance, the JAK2/STAT5 signaling pathway, which is involved in cell differentiation and survival, is capable of responding to a 1,000-fold change in the concentration of the hormone erythropoietin (Epo). 6 This pathway achieves the broad dynamic range for Epo response through the combined action of two regulatory mechanisms, governed by CIS and SOCS3. 6 In this signaling pathway, binding of Epo to its receptor induces JAK2 phosphorylation, followed by the activation of the transcription factor STAT5; STAT5 subsequently binds to the Epo receptor to generate a signaling output. 7 At low levels of Epo (10 -9 U/cell), CIS acts as a physical competitor that blocks STAT5 binding to the Epo receptor; at higher Epo levels (10 -6 U/cell), SOCS3 acts as a catalytic inhibitor for Epo-induced JAK2 phosphorylation. The combined action of these two regulators enables cells to respond to changes in Epo concentrations spanning a 1,000-fold range.
Unfortunately, most synthetic biosensors have a much narrower detection range. For example, typical biosensors based on affinity reagents such as antibodies rely on Langmuir binding physics to detect targets, such that their dynamic ranges are both inherently narrow (i.e. typically on the order of 81-fold) and extremely difficult to shift. [8] [9] Enzyme-based detection systems likewise have narrowly defined detection ranges because of intrinsic features of the enzyme in question, limiting control over the sensor dynamic range. 10 These fundamental limitations make it difficult to cope with wide variations in target concentration. 11-12 Many researchers have proposed ideas to extend the dynamic range of biosensors. For example, Ricci et al. have designed diverse DNA-based sensors that can achieve target detection across three orders of magnitude by making use of mutation-or allosteric regulation-based approaches. 13-16 However, even broader detection ranges are needed for many clinically relevant biological targets; for example, the physiological concentrations of HIV and prostate-specific antigen can vary over more than four orders of magnitude. 5, [17] [18] Therefore, there remains a strong need for novel strategies for the development of simple molecular biosensors with ultra-broad detection ranges.
We present here a novel biosensor design that couples together two DNA-based modules with distinct sensing modalities, enabling semi-quantitative target detection over a concentration range spanning more than five orders of magnitude. Our 'dualmode readout DNA' (DMRD) nanostructure is capable of detecting ATP at two different concentration ranges with two different readouts: fluorescence and absorbance. Moreover, the target detection range of the DMRD is highly tunable, and we have developed strategies for refining the sensitivity of both modules to shape the concentration range at which the sensor produces a response. Using this tuning approach, we demonstrate that our DMRD can successfully report ATP concentrations ranging from 1 μ M to 500 mM-a dynamic range spanning a 500,000-fold concentration difference that is presently impossible to obtain with either sensing mechanism alone, and represents the widest target detection range reported to date for a single DNA-based biosensor construct. 13
Results and Discussion
The modular design of the DMRD As a demonstration of our DMRD concept, we developed a modular ATP sensor ( Figure 1A) . The DMRD comprises two different sensing modules: a direct detection module (DDM), and an enzymatic detection module (EDM). The DDM (Figure 1A, top) is an adaptation of a previously published ATP aptamer, which has been engineered to fluoresce in a concentration-dependent manner. 19 The DDM consists of two single-stranded DNA fragments that have been respectively labeled with fluorescein (FAM) and Black Hole Quencher 1 (BHQ1). These strands remain separated in the absence of ATP, generating an unquenched fluorescent signal.
When ATP is added, these two fragments undergo binding-induced assembly that brings FAM and BHQ1 into close proximity, leading to a decrease of fluorescent signal at 535 nm. This aptamer-based DDM is designed to detect relatively low ATP
The two fragments of the DDM are in turn linked to the ends of the EDM, which provides the second readout mechanism (Figure 1A, bottom) . The EDM incorporates a DNAzyme, which folds into a G-quadruplex structure that forms a complex with hemin. 20 This DNAzyme/hemin complex exhibits modest peroxidase activity, but this catalytic activity is greatly enhanced by the presence of ATP. [21] [22] Such ATP-assisted peroxidation can cause rapid oxidation of substrates such as 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS), leading to accumulation of the product ABTS + . This ABTS + accumulation produces a proportional absorbance change at 418 nm, 23 generating a colorimetric signal that can be detected by the naked eye at high ATP concentrations (>1 mM).
These two modules can thus be combined to measure the presence of ATP at very different concentration ranges ( Figure 1B) . 
Optimizing DDM performance
The detection range of the DDM can be finely tuned through the use of antisense DNAs that modulate aptamer-target binding (Figure 2A) , yielding the capacity to discriminate ATP concentrations ranging from 1 μ M to 7.5 mM. These antisense sequences (Table S1) As expected, the relationship between the length of the antisense DNA and the resulting EC 50 value follows an Arrhenius plot (Figure S1) . This is because the main interactions expected from our DDM-between the DMRD and the antisense DNA, and between the aptamer and ATP-are based on Gibbs free energy change (△G).
From the extrapolation of our Arrhenius plot, we calculated the EC 50 value for the antisense-free DDM, which is equivalent to the K d of the ATP-binding aptamer (19.98 (Figure 2B) .
Our DDM consistently remained highly specific for ATP and other adenosine-derived molecules, without responding to other analytes with chemically similar structures ( Figure 2C and Figure S3 ). For example, when the DDM was hybridized with the 11nt antisense strand (AD11), it produced a similar reduction in fluorescence signal in response to adenosine, ATP, ADP, and AMP, but other nucleoside derivatives such as GTP, CTP, and UTP generated minimal signal change (Figure 2C) . Importantly, this target specificity of the DDM does not differ in the absence of antisense strand (Figure S3) , indicating that the antisense strand does not alter the nucleobasespecificity of the DDM. We therefore conclude that the presence of the antisense DNA only affects the thermodynamics of ATP binding, and thus the module's target sensitivity and detection range.
Optimizing EDM performance
We were likewise able to tune the responsiveness of the EDM by modulating the chemical conditions of the assay, which enabled us to achieve a dynamic range spanning roughly 1-500 mM with the same construct.
Tris(hydroxymethyl)aminomethane (Tris) binds antagonistically to the EDM, thereby
decreasing its catalytic activity, and can thus be used to shift its target detection range (Figure 3A) . This Tris-dependent catalytic inhibition is a new finding, and the underlying mechanism may be related to a previous report that Tris can trap intermediate radicals (·OH) and thereby block the peroxidation of cellular lipids. [24] [25] In the absence of Tris, the catalytic activity of the EDM is dramatically enhanced by the presence of ATP, which serves as a cofactor for the DNAzyme-catalyzed peroxidase reaction. The presence of Tris molecules has an inhibitory effect and reduces the rate of this reaction, such that a higher concentration of ATP is needed to restore the DNAzyme's peroxidase activity and thus generate an absorbance signal. We experimentally confirmed our ability to finely tune the dynamic range of the EDM by adjusting the concentration of Tris from 20 mM to 2.1 M, obtaining eight different calibration curves for ATP detection (Figure 3B) Thus, manipulating the chemical environment in this fashion can extend the ATP detection range achieved by the EDM from as low as 0.74 mM to as high as 506 mM.
Like the original DNAzyme, 22 our EDM retains excellent specificity for ATP in the presence of Tris, and can even distinguish between ATP and other adenosine-based compounds (Figure 3C) . ATP analogues such as GTP, CTP and UTP failed to generate an enhanced absorbance readout from the EDM in the presence of 20 mM
Tris. ADP and AMP produced a much weaker response, while adenosine itself showed negligible influence on the peroxidation reaction. We identified the same ATP specificity in experiments without Tris (Figure S4) , indicating that the addition of provides the energy for electron transfer, 26 whereas ATP binds to the DDM purely on the basis of intermolecular interactions.
Dual readouts for ultra-broad detection range
We have demonstrated that these two modules, combined with the respective tuning mechanisms described above, enable the DMRD sensor to achieve an exceptionally broad dynamic range for ATP detection-from 1 μ M to 500 mM, spanning more than five orders of magnitude. Consequently, we can quantitatively determine the ATP concentration in a sample by using this dual-readout system with two distinctive signals (Figure 4) . For example, an ATP-containing sample can be added to microplate wells containing the DMRD with varying lengths of antisense strands or concentrations of Tris, and both fluorescence and absorbance readouts can be measured from each well. If the unknown sample has an ATP concentration within the dynamic range for detection in a particular condition, its concentration can be represented by the resulting specific fluorescence and absorbance intensities. 
Conclusion
In this work, we integrated two different ATP-sensing modules in a single DNA molecule, which we have termed the DMRD, to achieve an extremely broad target It is important to note that we do not have to generate variants of the bioreceptor with different detection ranges through complicated processes such as mutational screening. In addition, we can make use of alternate signaling modalities in our DMRD construct by substituting FAM or ABTS with different signaling substrates. For instance, if we swap ABTS with luminol, the DMRD can be converted to a two-color fluorescence signaling system. In conclusion, we have demonstrated here the use of two different detection mechanisms in a monolithic biosensor construct to achieve an extremely wide range of target detection. Although our current modular approach is limited by the availability of nucleozymes, we believe that ongoing advancements in nucleic acid library screening techniques [27] [28] [29] [30] [31] [32] will allow their accelerated discovery, making our strategy available for many other molecular targets. 
